Schonfeld Strategic Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-175,478
| Closed | -$7.05M | – | 2006 |
|
|
2025
Q1 | $7.05M | Buy |
+175,478
| New | +$7.05M | 0.04% | 371 |
|
|
2024
Q3 | – | Sell |
-15,699
| Closed | -$851K | – | 1950 |
|
|
2024
Q2 | $851K | Sell |
15,699
-23,915
| -60% | -$1.3M | 0.01% | 1155 |
|
|
2024
Q1 | $2.78M | Buy |
39,614
+35,650
| +899% | +$2.5M | 0.02% | 728 |
|
|
2023
Q4 | $331K | Sell |
3,964
-9,917
| -71% | -$828K | ﹤0.01% | 1320 |
|
|
2023
Q3 | $409K | Sell |
13,881
-16,936
| -55% | -$499K | ﹤0.01% | 1129 |
|
|
2023
Q2 | $1.01M | Buy |
30,817
+3,383
| +12% | +$110K | 0.01% | 960 |
|
|
2023
Q1 | $965K | Sell |
27,434
-29,427
| -52% | -$1.04M | 0.01% | 965 |
|
|
2022
Q4 | $2.61M | Buy |
+56,861
| New | +$2.61M | 0.02% | 714 |
|
|
2022
Q3 | – | Sell |
-79,366
| Closed | -$3.12M | – | 2900 |
|
|
2022
Q2 | $3.12M | Buy |
79,366
+71,166
| +868% | +$2.8M | 0.03% | 564 |
|
|
2022
Q1 | $302K | Sell |
8,200
-93,500
| -92% | -$3.44M | ﹤0.01% | 1628 |
|
|
2021
Q4 | $4.64M | Buy |
101,700
+22,184
| +28% | +$1.01M | 0.04% | 441 |
|
|
2021
Q3 | $2.84M | Buy |
79,516
+59,216
| +292% | +$2.12M | 0.03% | 548 |
|
|
2021
Q2 | $402K | Buy |
+20,300
| New | +$402K | ﹤0.01% | 1259 |
|
|
2020
Q2 | – | Sell |
-13,263
| Closed | -$156K | – | 1254 |
|
|
2020
Q1 | $156K | Buy |
+13,263
| New | +$156K | 0.01% | 952 |
|
|
2016
Q4 | – | Sell |
-20,000
| Closed | -$184K | – | 563 |
|
|
2016
Q3 | $184K | Buy |
+20,000
| New | +$184K | 0.03% | 369 |
|